Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Daniel Duran
Clinical Research Coordinator
Az Health Sciences Division
Map Page
Research Area
pulmonary hypertension,
pulmonary fibrosis,
inhaled therapeutics,
clinical trial,
drug efficacy,
safety assessment,
right ventricular remodeling,
treprostinil therapy,
pulmonary artery pressure,
sirolimus
Grants
(3)
A Phase 2a Single-Arm, Open-Label, Exploratory Study to Assess the Effects of LAM-001 (Inhaled Sirolimus) for the Treatment of Pulmonary Hypertension
Active
·
2024
·
$0 / $261.3K
·
External
pulmonary hypertension,
sirolimus,
inhaled therapy
A Phase 4, Prospective, Multicenter, Single-Arm Study of a Mean Pulmonary Artery Pressure-Targeted Approach with Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Patient
Active
·
2023
·
$0 / $509.1K
·
External
pulmonary hypertension,
right ventricular remodeling,
treprostinil therapy,
pulmonary artery pressure
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
Active
·
2022
·
$0 / $207.1K
·
External
pulmonary fibrosis,
inhaled therapeutics,
clinical trial,
drug efficacy,
safety assessment
Collaborations
(6)
Franz Rischard
Mutual work: 2 Proposals﹒2 Grants
Collaboration Details
Kirsten Anderson
Mutual work: 3 Grants﹒3 Proposals
Collaboration Details
Gustavo Cornejo
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Maria Gordon
Mutual work: 2 Proposals﹒1 Supervisor﹒2 Grants
Collaboration Details
Maria Ambrose
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Page 1 of 2
Previous page
Next page
5+ Collaborators
$0 / $977.5K Funding
